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ABSTRACT
The biosynthesis of silver nanoparticles (Ag-NPs) using the hydrosol extract of the dry stem bark of
Acacia mearnsii as reducing and capping agents, and their antinociceptive properties are hereby
reported. By varying the temperature and reaction time, the temporal evolution of the optical
and morphological properties of the as-synthesized material was investigated. The NPs were
characterized by UV–visible absorption spectroscopy, transmission electron microscopy (TEM),
Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy-
dispersive x-ray spectroscopy (EDS) and x-ray diffractometry (XRD) The optical analyses show
that the position of the maximum surface plasmon resonance (SPR) peak is red-shifted as the
reaction temperature decreased. The TEM micrographs show that the as-synthesized Ag-NPs are
spherical while the X-ray diffraction shows that the material is highly crystalline with face-
centered cubic structures. The anti-inflammatory efficacy, analyzed by the formalin model,
indicates that the as-synthesized Ag-NPs are very effective, with an inhibition rate of about 76%.
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1. Introduction
Nanotechnology has become an interdisciplinary field of
research that is growing rapidly with integration into
other areas of science and technology (1). In this technol-
ogy, nanoparticles (NPs) are extremely important because
of their exceptionally small size and therefore exception-
ally large ratio of surface area to volume. This determines
their mechanical, physical, chemical, electrical, optical,
solubility and stability properties (2,3). Among the
various metal NPs like copper, titanium, zinc, iron and
gold, silver nanoparticles (Ag-NPs) have become desirable
as a result of their outstanding surface plasmonic reson-
ance (SPR) and their potent biological activities such as
antimicrobial, antibacterial, anti-inflammatory, anticancer,
antitumor and antimalarial activities (4–9).
Several methods have been employed for synthesizing
NPs; these include reverse phase micelles, chemical
reduction, electrochemical, sono-electrochemical and
laser ablation to mention a few. Among these methods,
chemical reduction offers a simple method of synthesis
which is achieved by reduction of the metal ion salt in sol-
ution. The method employs several organic reagents such
as sodium borohydride (NaBH4), hexadecylamine (HDA),
tri-n-octylphosphine (TOP), ethylene glycol, poly(vinyl pyr-
rolidine) (PVP) as the reaction solvent, reducing agent and
capping agent (10–14). However, these reagents/solvents
are toxic, expensive, environmentally unfriendly and
produce by-products that are toxic to both humans and
the environment. To circumvent this problem, greener
methods involving the use of plants, micro-organisms
and marine organisms have been reported.
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These methods have been proved to be effective,
simple, inexpensive, environmental friendly and yield
stable size-controlled Ag-NPs. The ability of plant and
micro-organisms to function in phytomining and phytor-
emediation of heavy metals further enhances their
potential for the biosynthesis of Ag-NPs (15). It has
been reported that certain magnetostatic bacteria can
synthesize magnetic NPs (16). Gardea-Torresdey et al.
reported the reduction of metallic solution using alfalfa
sprout. In this work, Au and Ag NPs between 6 and 10
nm with face-centered cubic (fcc) crystalline structure
were produced (17–18). In another development,
Huang et al. successfully prepared triangular and spheri-
cal Ag-NPs from the biomass of Cinnamomum camphora
at ambient temperature by controlling the amount of
biomass used (19). In addition to acting as reducing
agent, the plant materials can also act as stabilizing
agent. Bar et al. reported the synthesis of Ag-NPs using
Jatropa curcas latex. The stability of the material was
attributed to cyclic peptides present in the latex (20). In
another study, Velmurugan et al. reported the synthesis
of 10–20 nm Ag-NPs from the root extract of Zingiber offi-
cinale. The as-synthesized Ag-NPs showed high antibac-
terial efficacy against Staphylococcus spp. and Listeria spp.
The stability and high antibacterial property of the
material was attributed to the heterocyclic moieties
present in the alkaloids and flavonoids as the major con-
stituents of Zingiber officinale root (21).
Acacia mearnsii De Wild is a genus of the Mimosoi-
deae family, commonly known as black wattle, blue pas-
sionflower, green wattle and tan wattle. It originates from
the Australian continent, and has been spread to other
continents, including America, Asia and Africa. The econ-
omic importance of Acacia mearnsii as a source of
tannins led to its cultivation in South Africa (22). The
therapeutic uses of proanthocyanidins from Acacia
mearnsii include anti-obesity, anti-diabetes (23), inhi-
bition of the enzymes α-amylase and lipase, and
itching control (24). Anti-inflammatory studies revealed
that the extracts of Acacia mearnsii inhibit inflammatory
mediators at some dose levels (25–27). In addition, the
phytochemical analysis of the plant shows a high
content of tannins as reported by Kusano et al., who
isolated some proanthocyanidin oligomers such as
5-deoxyflavan-3-ols, 4’-O-methylrobinetididol, 3’-O-β-D-
glucopyranoside, syringic acid, butin, gallocatechin and
catechin from the plant (28). The essential oils from
this plant are composed mainly of phytol and cis-verbe-
neol, with high anti-inflammatory activity (29). In this
report, we explore the synthesis of Ag-NPs using the
hydrosol extract of the stem bark of Acacia mearnsii as
both reducing and capping agents. The effect of the
sequential evolution of the reaction temperature and
time on the optical and morphological properties was
investigated while the antinociceptive properties of the
as-synthesized Ag-NPs were analyzed with the formalin
model using Swiss mice.
2. Materials and methods
2.1. Plant material
The stem bark of Acacia mearnsii (Figure 1; inset (stem
bark)) was collected at the botanical garden of Walter
Sisulu University, Mthatha, Eastern Cape, South Africa
(31o36’08.35’S, 28o45’02.48’E). The plant was taxonomi-
cally identified by Mr. T. Dold, at the Selmar Schonland
Herbarium at Rhodes University in Grahamstown (GRA),
South Africa. A voucher number AOM001 was assigned
and collected, and a voucher specimen deposited in
the herbarium for future reference.
2.2. Chemicals and reagents
Silver nitrate (AgNO3) was purchased from Sigma-Aldrich
and used as purchased. The plant extract served as the
reducing and passivating agent.
2.3. Preparation of hydrosol extract of Acacia
mearnsii (AM)
Three hundred grams of the dried stem bark of each
sample were hydro-distilled in a Clevenger-type appar-
atus for 3 h at 100°C. Upon completion of the hydro-dis-
tillation, the plant residue in the flask was allowed to
cool, followed by filtration using 250 µm mesh sizes.
The extract was kept in an amber bottle, stored at 4°C
and analyzed within one week, before any mucus
could grow on it.
2.4. Synthesis of Acacia mearnsii dry stem extract
capped silver nanopaerticles (AMDS)-Ag-NPs
An aliquot (50 mL) of the Acacia mearnsii extract was
added to a three-necked flask, already equipped with a
temperature sensor and placed in a jacketed heating
mantle. 10 mL of a 0.1 mol/L AgNO3 aqueous solution
was transferred into the flask containing the plant
extract with constant stirring at room temperature, 40°
C and 60°C. The reaction vessel was covered with an
aluminum foil and placed in a dark cupboard to avoid
auto-reduction of the AgNO3 because of its photosensi-
tivity (30). The appearance of a milky color after few
minutes of reaction indicates formation of the Ag-NPs
as shown in Figure 1 (inset). Aliquots were withdrawn
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at different time intervals to monitor the growth of the
Ag-NPs.
2.5. Characterization
The UV–visible spectra were recorded using a UV 1650
PC-Shimadzu B UV–visible spectrophotometer (Shi-
madzu, Osaka, Japan). Transmission electron microscopy
(TEM) analysis was carried out using a JEOL JEM 2100
(TEM) operated at 200 KV. Samples were mounted on a
carbon-coated copper grid and then air dried. The crys-
tallinity of the Ag-NPs was examined by a Bruker aXS
D8 advanced diffractometer. The XRD patterns were
recorded at a scan speed of 4°/min with Cu Kα radiation
(λ = 1.5406 Å) operated at 40 KV and 40 mA. SEM analysis
was performed using a Philips XL-30 instrument (Philips,
Eindhoven), while EDXRF was carried out on a DX-700HS
spectrometer (Shimadzu) The FTIR spectra were
recorded over the range of 370–4000 cm−1 using an
FTIR spectrometer equipped with the universal ATR
sampling accessory. A small volume of the liquid
sample was concentrated via air drying before analysis.
2.6. Analgesic and inflammation analysis
2.6.1. Methods for the formalin test
Themethod of Prabhu et al. was used for the formalin test
with slightmodification (31). Four groups of Swissmice (n
= 6) were selected for the study. Group 1, the control
group, was treated with 0.09% NaCl. Group 2, the positive
control group, was treated with Aspirin (100 mg/kg).
Group 3, the AMDS test group, was treated with the
Acacia mearnsii dry stem extract (AMDS) (200 mg/kg).
Group 4, the AMDS-Ag-NPs test group, was treated with
the as-synthesized extract capped Ag-NPs (AMDS-Ag-
NPs) (200 mg/kg). This is summarized in Table 1.
One hour (1 h) after treatment with the various test
and control materials, animals were injected sub-plan-
tally with 100 μL of 2.5% formalin solution diluted in
saline. Swiss mice were used because of their high sensi-
tivity to pain. The noniceptive response in Swiss mice
was characterized by an intense period of biting and
licking of the rat paw for 5 min after injection of
diluted formalin to the hind paw. The biting and licking
subsided for 15 min (rest period) and later commenced
with periodic bites and licks of the hind paw for
20–30 min. Concurrent counts of bites and licks were
recorded for the neurogenic phase (phase 1) and anti-
inflammatory phases (phase 2) The percentage inhibition
was then calculated using the following formula:
Percentage inhibition = [(1− T/C)]× 100 (1)
where T is the number of times treated mice licked/bit
the injected paw; C is the number of times control
mice licked/bit the treated paw.
Figure 1. (A) Acacia mearnsii whole plant Inset: (a) stem bark (b) Color of the A. mearnsii extract (blue capped) and color of the solution
after the formation of AgNPs (white capped) (B) Absorption spectra of AM-Ag-NPs synthesized using 0.1 mol/L AgNO3 at 60°C at differ-
ent reaction times.
Table 1. Experimental method.
Group # n Group designation Treatment Concentration
1 6 Control NaCl 0.09%
2 6 Positive control Aspirin 100 mg/kg
3 6 AMDS test AMDS 200 mg/kg
4 6 AMDS-Ag-NPs test AMDS-Ag-NPs 200 mg/kg
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2.6.2. Statistical analysis
Results were expressed as mean ± SEM. Statistical ana-
lyses were carried out using one-way analysis of variance
(ANOVA) followed by Dunnett’s post hoc test, and values
were considered significant at p < .05.
3. Results and discussion
3.1. Optical characterization
3.1.1. UV–visible spectroscopic analysis
In this reaction, the hydrosol extract of A. mearnsii acted
as both reducing and stabilizing agents. Preliminary
observation of color change from deep brown to milky
color within 15 min of reaction confirmed the reduction
of AgNO3 to Ag-NPs (Figure 1(A) inset) The whole process
is a redox reaction with silver nitrate acting as the
oxidant and Ag-NPs are the reduction product, while
the phytochemicals in the plant extracts act as the redu-
cing and passivating agent. Based on our earlier reports
(29), this plant contains considerable amounts of mono-
terpenoids, sesquiterpenes and phytols. The OH of the
phytol group reduced the Ag+ ions to Ag0 while the
amide group of the monoterpenoids and sesquiterpene
passivated and stabilized the NPs. The surface plasmon
resonance (SPR) peak corresponding to the excitation
of longitudinal plasmon vibrations of Ag-NPs was
observed at 480 nm. Figure 1(B) depicts the SPR
spectra of the as-synthesized AM-AgNPs at a tempera-
ture of 60°C. The position of the SPR peak remains the
same after 15 min and for the rest of the reaction time.
The absence of any significant change in the SPR peak
position and the shape of the spectra after 15 min is an
indication that the particle size and size distribution
remain the same throughout the reaction time. This
shows that Acacia mearnsii extract reduction of AgNO3
to Ag-NPs is a very fast reaction. Since all the AgNO3
were reduced within 15 min, the reaction can be
stopped after 15 min under this synthetic condition.
At 40°C reaction temperature (Figure 2(A)), the pos-
ition of the SPR peak is red-shifted to 490 nm with broad-
ening compared to the Ag-NPs synthesized at 60°C. This
indicates formation of larger particles with broad size dis-
tribution. However, the growth kinetics follow the same
pattern as growth kinetics at 60°C, i.e. the position of
the SPR peak and the shape of the spectrum remain
the same after 15 min reaction time. The room tempera-
ture reaction did not show any distinctive SPR peak
(Figure 2(B)). The spectra show resemblance to that of
the plant extract indicating that there was no reduction
at this temperature. These results show that the use of
Acacia mearnsii extracts as reducing and stabling
agents is temperature dependent. The smaller particle
size and narrow size distribution at 60°C can be attribu-
ted to the high concentration of phytochemicals
released at this temperature which led to faster
reduction and more effective passivation. Dai and
Munper reported that Acacia mearnsii contains phyto-
chemicals embedded in the cell cavity of the plant,
which can be released at high temperatures (1).
3.1.2. Fourier transform infrared spectroscopy
To determine the probable bio-reducing functional
groups liable for the reduction and passivation of the
Ag-NPs’ surface under this syntheticmethod, FTIR analysis
Figure 2. (A) Absorption spectra of AM-AgNPs synthesized using 0.1 mol/L AgNO3 at 40°C and (B) room temperature at different reac-
tion time.
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was performed. Figure 3 shows the spectra of the crude
material and that of the as-synthesized AM-Ag-NPs.
Characteristic changes in the position, emergence of
new peaks and change in the peak intensities are some
confirmatory parameters for the biomolecules respon-
sible for the reduction and successful capping of the as-
synthesized Ag-NPs. The changes and assignments of
the peaks are outlined in Table 2. Representative func-
tional groups of some biomolecules such as proteins, ses-
quiterpenes, phytols, flavonoids, alkaloids and terpenoids
were observed from the crude extract. The free O–H of
alcohols andphenols, C=Oof the amide groupof proteins,
C–N of the amines, alkaloids, N–O of nitro-containing ter-
penoids, –OCH3 of flavonols and halogen peaks were
identified. In the as-synthesized AM-Ag-NPs, the broad-
ness of the peak increases and the peaks assigned to
the free O-H stretching vibration shifted from 3715.8 to
3855.5 cm−1. In addition, the C=O of the amide which
appeared at 1619.3 cm−1 in the crude extract was
shifted to 1608.4 cm−1. Furthermore, the peaks at
1452.7, 1320.1, 1204.0 and 1154.9 cm−1 assigned to the
C=C of aromatics, C–N of amides, C–N of amines and C–
O of ester stretching vibrations in the AM extract shifted
to 1440.06, 1396.95, 1278.89, 1192.51, respectively. The
red shifting of the amide, amine and ester C–O stretching
vibration in comparison with the crude extract indicates
the involvement of theNH and the proton of the C–Ocon-
taining compounds in the reduction of Ag ion to Ag-NPs
and its subsequent capping. However, the blue shifting
of the C=C aromatic bond indicates the interaction
between the aromatic group of the flavonols of the
extract with the Ag-NPs’ surface. Other peaks at 1030.1
and 523.1 cm−1 are attributed to the presence of ether
linkage and bending vibration found in both the extract
and the as-synthesized Ag-NPs. This further confirmed
the reduction and capping of the Ag-NPs by the plant
extract. The previously observed peak at 2124.6 cm−1,
earlier attributed to the C°C triple bond stretching
vibrations in the AM extract, disappeared with the emer-
gence of a new peak at 2856.7 cm−1 assigned to the C–H
stretching of alkyl groups. Thus, the bio-reduction and
stabilization of the as-synthesized Ag-NPs could be attrib-
uted to the presence of nerolidol, phytol, flavonols, verbe-
none and monoterpenoid functional groups present in
the plant extract and the synergistic effect of other
Figure 3. FTIR of crude sample and synthesized AM-AgNPs at 60°C.
Table 2. FTIR analysis of the crude extract and the as-synthesized
AM-AgNPs.
λ cm−1 of
crude
extract
λ cm−1 of
AMDS-Ag-NPs Assignment Reference
3751.8 3855.5 Free O–H of the alcohol (35)
3413.7 Disappear C–H-stretch of terminal alkynes (36)
3200 3150.4 N–H bond of the amide (3,36)
2923.8 2910.3 C–H stretch of CH3 (1)
Absent 2856.7 C–H stretching for alkanes (37)
2124.6 Disappear C°C bond of terminal alkynes
(mono substituted)
(36)
1619.3 1608.4 C=O bond of amide (1)
1516.2 1518.2 N–O bond of nitro compounds (38)
1452.7 1440.1 (C=C–C of aromatic chromones
of flavonoids
(39)
1320.1 1397.0 C–N bond of amide (3)
Absent 1318.35 Acyl and phenyl C–O, Ag/A.M
vibrations
(40)
1204.0 1278.9 C–N bond of the amines (41)
1154.9 1192.5 C–O–C bond of ester (42)
1030.7 1030.1 –OCH3 of ether linkage (19)
842.6–
662.2
850–600 C-halogen bonds, C–H bends of
the alkynes, Ag–O
(deformation) bond of the
silver metal
(43)
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functional groups earlier highlighted. Earlier reports had
indicated the ability of the protein moiety of amines,
amides and peptides, to bind to nanoparticle surfaces,
thereby acting as capping agents preventing aggregation
(32–34).
3.2. Morphological studies
3.2.1. SEM and EDS studies
The morphology of the as-synthesized Ag-NPs investi-
gated using scanning electron microscopy (SEM) is
shown in Figure 4. The micrographs show that the
surface of the crude extracts is coarse while that of the
as-synthesized Ag-NPs shows little follicles (Figure 4(B))
The formation of Ag-NPs and their purity was further
confirmed using EDS (Figure 5) The EDS spectrum of
the crude extract (Figure 5(A)) shows C and O as the
major peaks with traces of Cl, N and S. However, the
Ag-peak is conspicuously absent. On the other hand,
the EDS spectrum of the as-synthesized Ag-NPs
(Figure 5(B)) shows the Ag peak as the major peak with
traces of Cl, C, O, N and S. The weight percentage of
the Ag, Cl, C, O, N and S are 75.4%, 11.1%, 0.9%, 12.5%,
1.0% and 0.1%, respectively. This further confirms the for-
mation and the purity of the as-synthesized Ag-NPs.
3.2.2. XRD and TEM analyses
The crystallinity of the as-synthesized Ag-NPs was con-
firmed using XRD analysis. Figure 6(A) shows the
typical XRD pattern of the Ag-NPs synthesized at 40
and 60°C. The XRD pattern shows diffraction peaks at
2θ values of 38.63, 46.54, 64.97, 77.42 and 81.99, respect-
ively, corresponding to the (111), (200), (220), (311) and
(222) crystallographic planes of the face-centered cubic
crystalline structures of metallic Ag (JCPDS no 04-0783).
The broad nature of the XRD peaks is attributed to the
nano-crystalline nature of the Ag-NPs. The unassigned
peaks may result from the bio crystalline particles of
Figure 4. SEM micrographs of crude Acacia mearnsii (A) and as-synthesized AM-Ag-NPs (B) at 60°C.
Figure 5. EDS spectra of AMDS pure sample (A) and as-synthesized AM-AgNPs (B) at 60°C.
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the plant extract (1). The particle sizes as calculated using
the Debye–Sherrer’s formula (44) are 20.77 and 24.91 nm
for Ag-NPs synthesized at 60°C and 40°C, respectively.
These results are in alignment with the optical analyses.
The typical TEM micrograph of the as-synthesized AM-
Ag-NPs at 60°C (Figure 6(B)) shows that the material is
spherical in shape while the presence of clear singular
reciprocal points in the fast Fourier transform (FFT) pat-
terns (Figure 6(C)) further confirmed the high crystallinity
of the as-synthesized material indicated by the XRD
analysis. The particle diameter, as determined from the
TEM images using the size distribution curve (Figure 6
(D)), is in the range 5–60 nm with an average particle
size of 19.95 ± 7.76 nm, in alignment with calculated
values and optical data.
3.3. Antinociceptive and inflammation activity
The formalin-induced test is a pain model used to
analyze both the analgesic and anti-inflammatory prop-
erties simultaneously. Formalin induces pain of moderate
intensity characterized by irritation, tissue damage and
edema formation due to the release of inflammatory
mediators (45). Typically, formalin-induced pain involves
two phases. The initial phase is linked to the stimulation
of nociceptors and principal afferent fibers by the forma-
lin, triggering the liberation of bradykinin and tachyki-
nins which occurs for 5 min (46). The latter phase,
which lasts for 20–30 min after injection, is accompanied
by the discharge of inflammation facilitators such as
prostaglandins, cytokines, histamine, nitric oxide (NO)
and serotonin. In addition, these phases are inhibited
by different classes of drugs. Opioid drugs inhibit the
early phase and non-steroidal, anti-inflammatory drugs
(NSAIDs) and opioid drugs inhibit the latter phase.
Table 3 shows the antinociceptive effect of oral treatment
with AMDS-Ag-NPs on formalin-induced pain. In this
model, a lower number of licks is an indication of high
inhibition. As expected, aspirin used as the standard
drug significantly inhibited the first phase (83%) and
second phase (73%) of the test which is expected for a
non-steroidal drug. The crude sample (AMDS) and the
AMDS-Ag-NPs exhibited high activity at the inflammatory
phase with 70% and 76% inhibition, respectively, at a dose
level of 200 mg/kg. Ag-NPs had been shown to possess
very high wound healing and anti-inflammation effects
due to their high rate of absorption into cell membranes
and ability to modulate cytokine production (47–49).
Figure 6. (A) A typical XRD pattern of AM-Ag-NPs synthesized at 60°C and 40°C. HRTEM image of AM-AgNPs (B) with corresponding FFT
(C) and size distribution (D).
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The activity of the as-synthesized Ag-NPs was significant
to an order of p > .01 at both phases and the result
shows that the NPs possess better activity than the
crude plant at the second phase only. In addition, the
anti-inflammatory activity of the as-synthesized Ag-NPs
at a dosage of 200 mg/kg is almost similar to 100 mg/kg
dose level of the standard drug (Aspirin) with a signifi-
cance level of p < .01. This indicates that the as-syn-
thesized AMDS-Ag-NPs can be used as a drug to
modulate various inflammatory mediators.
4. Conclusion
Ag-NPs were successfully synthesized via bio-reduction
of silver nitrate solutions using the stem bark hydrosol
of Acacia mearnsii. The plant extract acted as both redu-
cing and capping agents while the optimization of the
synthetic parameters shows 60°C as the optimum temp-
erature for the synthesis. Furthermore, the reduction
reaction using the Acacia mearnsii extract is very fast,
and can be completed within 15 min. The morphological
analyses show that the as-synthesized AM-Ag-NPs are
spherical in shape with face-centered cubic (fcc) crystal-
line structure while the FTIR analyses showed that the
hydroxyl, alkyne, carboxyl and amide groups of the
monoterpenoids, sesquiterpenes and phytols present in
the Acacia mearnsii extract were liable for the bio-
reduction of the silver ions to NPs and the consequent
passivation of the surface. The anti-inflammatory effi-
cacy, analyzed by the formalin model, reveals that the
as-synthesized Ag-NPs were more effective than the
crude extract at the second phase (inflammation
phase) with an inhibition that is close to that of the stan-
dard drug, Aspirin. This investigation shows that Ag-NPs
synthesized from the stem bark of Acacia mearnsii can be
used as a drug to modulate various inflammatory
mediators such as cytokines, prostaglandins, NO, hista-
mine and serotonin.
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